Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
MOA (Quick Clinical Overview): Ozempic is a GLP-1 receptor agonist that: Enhances glucose-dependent insulin secretion Suppresses inappropriate glucagon release Delays gastric emptying Reduces appetite and caloric intake This results in improved glycemic control, weight reduction, and cardiovascular risk benefit in eligible T2DM patients
Eberl A, Heumann S, Brckner T, Araujo R, Cavaco-Paulo A, Kaufmann F, Guebitz GM
PMID: 3525654 Messerli FH, Eslava DJ (2008): Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence
Below are the major areas where Semax has shown promise in research settings
US$ 26.48
US$ 23.79
US$ 27.34
US$ 24.88
US$ 28.08
US$ 28.08
